-
Product Insights
NewCaM Kinase – Drugs In Development, 2024
The CaM Kinase pipeline drugs market research report outlays comprehensive information on the CaM Kinase targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Central Nervous System, Oncology, and Respiratory which include indications of Arrhythmias, Congestive Heart Failure (Heart Failure), Alzheimer's Disease, Parkinson's Disease, Prostate Cancer, Triple-Negative Breast Cancer (TNBC), and Asthma. It also reviews key players...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CAM-101 in Keratoconjunctivitis Sicca (Dry Eye)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CAM-101 in Keratoconjunctivitis Sicca (Dry Eye) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CAM-101 in Keratoconjunctivitis Sicca (Dry Eye) Drug Details: CAM-101...
-
Innovation Ranking
Innovation Ranking – Turkiye Sise ve Cam Fabrikalari AS
Turkiye Sise ve Cam Fabrikalari AS (Sisecam), a subsidiary of Turkiye IS Bankasi AS involves in production and sale of glass and chemicals. The company offers flat glass, coated glass, mirror glass, patterned glass, laminated glass, solar power glass, automotive and encapsulated glass. It also provides chemical products such as soda and chromium chemicals, industrial raw materials, glass fiber, vitamin K3 and sodium metabisulfite. Sisecam produces designed glassware and glass packaging for various industries including pharmaceuticals, food, beverages and cosmetics....
-
Sector Analysis
NewCAD/CAM Systems and Materials Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
CAD/CAM Systems and Materials Market Report Overview The CAD/CAM systems and materials market size was valued at $3.93 billion in 2023 and is expected to grow at a CAGR of more than 5% during the forecast period 2023 and 2033. CAD/CAM materials are used to fabricate temporary and permanent dental restorations on a CAD/CAM system. CAD/CAM Systems and Materials Market Outlook 2023-2023 ($ Billion) Buy the Full Report for More Insights on the CAD/CAM Systems and Materials Market Forecast, Download...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CX-2051 in Epithelial Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CX-2051 in Epithelial Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CX-2051 in Epithelial Tumor Drug Details: CX-2051 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CX-2051 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CX-2051 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CX-2051 in Solid Tumor Drug Details: CX-2051 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CX-2051 in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CX-2051 in Metastatic Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CX-2051 in Metastatic Colorectal Cancer Drug Details: CX-2051 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Octreotide LA in Neuroendocrine Tumors
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Octreotide LA in Neuroendocrine Tumors report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Octreotide LA in Neuroendocrine Tumors Drug Details: Octreotide long-acting (CAM-2029)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Octreotide LA in Acromegaly
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Octreotide LA in Acromegaly report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Octreotide LA in Acromegaly Drug Details: Octreotide long-acting (CAM-2029) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Octreotide LA in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Octreotide LA in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Octreotide LA in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) Drug...